Home Cancer

Cancer

Dr. Reddy’s Laboratories announces the launch of Hervycta® (trastuzumab biosimilar) in India

Mumbai, July 28, 2018: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY) announced today that it has launched Hervycta® (Trastuzumab), a biosimilar of Roche’s Herceptin® in India, indicated for the treatment of HER2-positive cancers (early breast cancer, metastatic breast cancer...

Bead Chemo Embolisation becoming the most preferred way of treatment for Liver cancer patients

This non-surgical revolutionary treatment has no side effects and higher survival rate, says Dr. Sandip Jhala, Interventional Specialist, Apollo Hospitals-Ahmedabad Ahmedabad, March 16, 2018: Hepatocellular carcinoma or HCC is a Primary Liver Cancer (which means it originates in liver and is...

Roche names Pao as Swiss R&D head after Reed exits

New Delhi, March 12, 2018: Swiss drugmaker Roche (ROG.S) said it will put a cancer specialist at the helm of its Swiss-based research efforts in April, after the scientist who led the unit for five years resigned for personal reasons. The...

Study on Cancer Patients

New Delhi, March 12, 2018: According to an article “Global surveillance of trends in cancer survival 2000-14 (CONCORD-3), published in LANCET, there are differences in survival rates across countries. The study estimates 5-year survival for breast cancer as 88.2% in...

Government of Telangana, Tata Trusts sign MoU to provide state-wide cancer care

Hyderabad, March 04, 2018: The Government of Telangana and Tata Trusts today announced a Memorandum of Understanding to deliver high quality affordable cancer care through a three-tier model, and develop academic and research capabilities in the state. The MoU was...

Pharma goliath Roche is purchasing malignancy tech startup Flatiron Well being for $1.9 billion

New Delhi, February 20, 2018: Pharma goliath Roche is gaining Flatiron Well being for $1.9 billion. The New York-based malignancy innovation startup had already been esteemed at $1.2 billion subsequent to raising $175 million from financial specialists including Roche. Flatiron gathers clinical...

New potential bosom tumor medicate distinguished

New Delhi, February 16, 2018: Scientists, including an Indian-American specialist, have distinguished a particle that can enable treat to bosom growth, offering would like to patients who have turned out to be impervious to customary treatments. The first-in-class atom close down...

Sunil Chhetri kicks off Narayana Health City’s #Don’tBeLate campaign

Bengaluru, February 09, 2018: In an effort to create awareness about the importance of early detection in the fight against cancer, Narayana Health City today launched a unique campaign titled #DontBeLate. The campaign was launched by Sunil Chhetri the...

Columbia Asia yeshwanthpur witnesses a rare case of three generation cancer survivors.

Dr. Neelesh Reddy, Consultant Medical Oncologist, Columbia Asia Referral Hospital, Yeshwanthpur New Delhi, February 08, 2018: Self-pity and blaming luck is easier to succumb to when faced with a crisis like cancer. Lots of Women get into the trauma and accept...

Columbia Asia Yeshwanthpur Witnesses a Rare Case Of Three Generation Cancer Survivors.

Dr. Neelesh Reddy, Consultant Medical Oncologist, Columbia Asia Referral Hospital, Yeshwanthpur New Delhi, February 08, 2018: Self-pity and blaming luck is easier to succumb to when faced with a crisis like cancer. Lots of Women get into the trauma and accept...